In 2021, with the Decision of the CPC Central Committee and State Council on Optimizing Reproductive Policies to Promote Long-term Balanced Development of Population, the three-child policy and supporting measures were introduced, the issue of fertility attracted more and more attention from the state and society, and assisted reproduction has become a powerful driving force for a "fertility-friendly society". By 2022, the population of China decreased by 850,000 people! In 2023, China witnessed the first negative growth in the infertility rate in 61 years. It has increased from 2.5%-3% 20 years ago to 12.5%-15%, the number of patients has more than 50 million and the demand for assisted human reproduction technology has increased dramatically, which will bring the market demand for assisted reproduction services continue to rise, the entire future of China's assisted reproduction technology market demand scale will reach 434.1 billion RMB!

China's assisted reproduction market is expected to reach 85.43 billion yuan by 2025, with a CAGR (compound annual growth rate) of 14.5% from 2021 to 2025. At present, due to the uneven distribution of the quantity and quality of assisted reproduction institutions in China, the fact that assisted reproduction technology still needs to be continuously developed to ensure the success rate of treatment for more older patients, and that the top-level design in the field of assisted reproduction is not yet perfect, many patients have made overseas assisted reproduction technology their priority, and nowadays overseas assisted reproduction has become a global business that is changing day by day.